Summary
A Health and Human Services (HHS) official, Adm. Brian Christine, warned of irreversible risks associated with gender procedures for minors, supporting the Trump administration's new rule to restrict Medicaid and CHIP funding for such treatments. The rule, which takes effect on October 13, will bar federal funding for puberty blockers, hormone therapy, and surgeries for gender dysphoria in minors, with a six-month tapering-off period for those currently receiving treatment.